Skip to main content
Top
Published in: Abdominal Radiology 12/2018

01-12-2018

Multi-institutional analysis of CT and MRI reports evaluating indeterminate renal masses: comparison to a national survey investigating desired report elements

Authors: Eric M. Hu, Andrew Zhang, Stuart G. Silverman, Ivan Pedrosa, Zhen J. Wang, Andrew D. Smith, Hersh Chandarana, Ankur Doshi, Atul B. Shinagare, Erick M. Remer, Samuel D. Kaffenberger, David C. Miller, Matthew S. Davenport

Published in: Abdominal Radiology | Issue 12/2018

Login to get access

Abstract

Purpose

To determine the need for a standardized renal mass reporting template by analyzing reports of indeterminate renal masses and comparing their contents to stated preferences of radiologists and urologists.

Methods

The host IRB waived regulatory oversight for this multi-institutional HIPAA-compliant quality improvement effort. CT and MRI reports created to characterize an indeterminate renal mass were analyzed from 6 community (median: 17 reports/site) and 6 academic (median: 23 reports/site) United States practices. Report contents were compared to a published national survey of stated preferences by academic radiologists and urologists from 9 institutions. Descriptive statistics and Chi-square tests were calculated.

Results

Of 319 reports, 85% (271; 192 CT, 79 MRI) reported a possibly malignant mass (236 solid, 35 cystic). Some essential elements were commonly described: size (99% [269/271]), mass type (solid vs. cystic; 99% [268/271]), enhancement (presence vs. absence; 92% [248/271]). Other essential elements had incomplete penetrance: the presence or absence of fat in solid masses (14% [34/236]), size comparisons when available (79% [111/140]), Bosniak classification for cystic masses (54% [19/35]). Preferred but non-essential elements generally were described in less than half of reports. Nephrometry scores usually were not included for local therapy candidates (12% [30/257]). Academic practices were significantly more likely than community practices to include mass characterization details, probability of malignancy, and staging. Community practices were significantly more likely to include management recommendations.

Conclusions

Renal mass reporting elements considered essential or preferred often are omitted in radiology reports. Variation exists across radiologists and practice settings. A standardized template may mitigate these inconsistencies.
Literature
1.
go back to reference Hollingsworth JM, Miller DC, Daignault S, et al. (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98:1331–1334CrossRef Hollingsworth JM, Miller DC, Daignault S, et al. (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98:1331–1334CrossRef
2.
go back to reference Lipworth L, Tarone RE, McLaughlin JK (2006) The epidemiology of renal cell carcinoma. J Urol 176:2353–2358CrossRef Lipworth L, Tarone RE, McLaughlin JK (2006) The epidemiology of renal cell carcinoma. J Urol 176:2353–2358CrossRef
3.
go back to reference Ljungberg B, Campbell SC, Choi HY, et al. (2011) The epidemiology of renal cell carcinoma. Eur Urol 60:615–621CrossRef Ljungberg B, Campbell SC, Choi HY, et al. (2011) The epidemiology of renal cell carcinoma. Eur Urol 60:615–621CrossRef
4.
go back to reference Bjorge T, Tretli S, Engeland A (2004) Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 160:1168–1176CrossRef Bjorge T, Tretli S, Engeland A (2004) Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 160:1168–1176CrossRef
5.
go back to reference Silverman SG, Israel GM, Herts BR, et al. (2008) Management of the incidental renal mass. Radiology 249:16–31CrossRef Silverman SG, Israel GM, Herts BR, et al. (2008) Management of the incidental renal mass. Radiology 249:16–31CrossRef
7.
go back to reference Israel GM, Bosniak MA (2005) How I do it: evaluating renal masses. Radiology 236:441–450CrossRef Israel GM, Bosniak MA (2005) How I do it: evaluating renal masses. Radiology 236:441–450CrossRef
8.
go back to reference Bosniak MA (2011) The Bosniak renal cyst classification: 25 years later. Radiology 262:781–785CrossRef Bosniak MA (2011) The Bosniak renal cyst classification: 25 years later. Radiology 262:781–785CrossRef
9.
go back to reference Silverman SG, Israel GM (2015) Trinh, Qouc-Dien. Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology 275:28–42CrossRef Silverman SG, Israel GM (2015) Trinh, Qouc-Dien. Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology 275:28–42CrossRef
12.
go back to reference Davenport MS, Hu EM, Smith AD, et al. (2017) Reporting standards for the imaging-based diagnosis of renal masses on CT and MRI: a national survey of academic abdominal radiologists and urologists. Abdom Radiol 42:1229–1240CrossRef Davenport MS, Hu EM, Smith AD, et al. (2017) Reporting standards for the imaging-based diagnosis of renal masses on CT and MRI: a national survey of academic abdominal radiologists and urologists. Abdom Radiol 42:1229–1240CrossRef
13.
go back to reference Hindman N, Ngo L, Genega EM, et al. (2012) Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology 265:468–477CrossRef Hindman N, Ngo L, Genega EM, et al. (2012) Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology 265:468–477CrossRef
14.
go back to reference Silverman SG, Mortele KJ, Tuncali K, et al. (2007) Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation. RadioGraphics 27:1131–1143CrossRef Silverman SG, Mortele KJ, Tuncali K, et al. (2007) Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation. RadioGraphics 27:1131–1143CrossRef
15.
go back to reference Pedrosa I, Sun MR, Spencer M, et al. (2008) MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. RadioGraphics 28:985–1003CrossRef Pedrosa I, Sun MR, Spencer M, et al. (2008) MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. RadioGraphics 28:985–1003CrossRef
16.
go back to reference Sun MR, Ngo I, Genega EM, et al. (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes—correlation with pathologic findings. Radiology 250:793–802CrossRef Sun MR, Ngo I, Genega EM, et al. (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes—correlation with pathologic findings. Radiology 250:793–802CrossRef
18.
go back to reference Canvasser NE, Kay FU, Xi Y, et al. (2007) Diagnostic accuracy of multiparametric magnetic resonance imaging to identify clear cell renal cell carcinoma in cT1a renal masses. J Urol 198:780–786CrossRef Canvasser NE, Kay FU, Xi Y, et al. (2007) Diagnostic accuracy of multiparametric magnetic resonance imaging to identify clear cell renal cell carcinoma in cT1a renal masses. J Urol 198:780–786CrossRef
19.
go back to reference Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267:444–453CrossRef Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267:444–453CrossRef
20.
go back to reference Oliva MR, Glickman JN, Zou KH, et al. (2009) Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology. AJR Am J Roentgenol 192:1524–1530CrossRef Oliva MR, Glickman JN, Zou KH, et al. (2009) Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology. AJR Am J Roentgenol 192:1524–1530CrossRef
21.
go back to reference Kutikov A, Uzzo RG (2009) The R.E.N.A.L nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location, and depth. J Urol 182:844–853CrossRef Kutikov A, Uzzo RG (2009) The R.E.N.A.L nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location, and depth. J Urol 182:844–853CrossRef
22.
go back to reference Dodelzon K, Mussi TC, Babb JS, et al. (2012) Prediction of growth rate of solid renal masses: utility of MR imaging features—preliminary experience. Radiology 262:884–893CrossRef Dodelzon K, Mussi TC, Babb JS, et al. (2012) Prediction of growth rate of solid renal masses: utility of MR imaging features—preliminary experience. Radiology 262:884–893CrossRef
23.
go back to reference Dickerson E, Davenport MS, Syed F, et al. (2017) Effect of template reporting of brain MRIs for multiple sclerosis on report thoroughness and neurologist-rated quality: results of a prospective quality improvement project. J Am Coll Radiol 14:371–379CrossRef Dickerson E, Davenport MS, Syed F, et al. (2017) Effect of template reporting of brain MRIs for multiple sclerosis on report thoroughness and neurologist-rated quality: results of a prospective quality improvement project. J Am Coll Radiol 14:371–379CrossRef
24.
go back to reference Brook OR, Brook A, Vollmer CM, et al. (2015) Structured reporting of multiphasic CT for pancreatic cancer: potential effect on staging and surgical planning. Radiology 274:464–472CrossRef Brook OR, Brook A, Vollmer CM, et al. (2015) Structured reporting of multiphasic CT for pancreatic cancer: potential effect on staging and surgical planning. Radiology 274:464–472CrossRef
25.
go back to reference Sahni VA, Silveira PC, Sainani NI, Khorasani R (2015) Impact of a structured report template on the quality of MRI reports for rectal cancer staging. AJR Am J Roentgenol 205:584–588CrossRef Sahni VA, Silveira PC, Sainani NI, Khorasani R (2015) Impact of a structured report template on the quality of MRI reports for rectal cancer staging. AJR Am J Roentgenol 205:584–588CrossRef
26.
go back to reference Al-Hawary MM, Francis IR, Chari ST, et al. (2014) Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology 270:248–260CrossRef Al-Hawary MM, Francis IR, Chari ST, et al. (2014) Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology 270:248–260CrossRef
Metadata
Title
Multi-institutional analysis of CT and MRI reports evaluating indeterminate renal masses: comparison to a national survey investigating desired report elements
Authors
Eric M. Hu
Andrew Zhang
Stuart G. Silverman
Ivan Pedrosa
Zhen J. Wang
Andrew D. Smith
Hersh Chandarana
Ankur Doshi
Atul B. Shinagare
Erick M. Remer
Samuel D. Kaffenberger
David C. Miller
Matthew S. Davenport
Publication date
01-12-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 12/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1609-x

Other articles of this Issue 12/2018

Abdominal Radiology 12/2018 Go to the issue

Classics in Abdominal Radiology

Enhanced peritoneal stripe sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.